COMMENTARY

• COMMENTARY／Global Pharmas Enhance Their Presence in Japan
  July 13, 2009

• COMMENTARY／Additional Price Cuts for Long-listed Original Drugs
  June 29, 2009

• COMMENTARY／Clinical Applications of ADCs Coming Closer to Reality
  June 29, 2009

• SURVEY／RLS Takes Almost Four Years before Being Diagnosed
  June 22, 2009

• COMMENTARY／JSHP to Promote Use of Generics
  June 8, 2009

• COMMENTARY／Combination Drugs Becoming a "Boom"
  June 1, 2009

• COMMENTARY／Clearer Criteria Needed for Patent Period Restoration
  May 4, 2009

• COMMENTARY／Why Does the Use of Generics Not Increase?
  April 27, 2009

• EMTs Allowed to Administer Epipen
  April 27, 2009

• COMMENTARY／Medway Data Falsification to Make Blood Product Self-Sufficiency Difficult
  April 20, 2009

• The First Round Results of GE Amlodipine (2)- Making No Surprise Moves Leads to Success -
  April 6, 2009

• COMMENTARY／Worst Scenario Coming True due to Heated Competition among Wholesalers
  March 23, 2009

• Unexpected Demand for ActHIB Causes Shortage of Supply
  March 16, 2009

• COMMENTARY／Aggressive Overseas Investments Affect Business of Top-4 Pharmas
  February 23, 2009

• COMMENTARY／National Consensus Needed to Balance Soaring Costs of New Drugs against Their Benefits
  February 16, 2009

• Majority of People Have Misconceptions about Antibacterials: Pfizer Survey
  February 9, 2009

• Patent Expiration of Blockbusters and New Breakthrough Candidates from Japanese Pharmaceutical Companies
  February 9, 2009

• Paltac/Alfresa Merger Plan Canceled, but Distribution Reform Remains to Be Done
  February 2, 2009

• COMMENTARY／Industry Should Guarantee Development of Innovative Drugs and Use of More Generics
  January 19, 2009

• COMMENTARY／Aiming at Further Growth beyond Global Recession
  January 12, 2009

ページ